Skip to main content
The Kaohsiung Journal of Medical Sciences logoLink to The Kaohsiung Journal of Medical Sciences
. 2011 May 12;27(8):299–306. doi: 10.1016/j.kjms.2011.03.010

Proteomic comparison of human embryonic stem cells with their differentiated fibroblasts: Identification of 206 genes targeted by hES cell‐specific microRNAs

Zong‐Yun Tsai 1, Chi‐Hsien Chou 2, Chi‐Yu Lu 3, Sher Singh 4, Sung‐Liang Yu 5, Steven Shoei‐Lung Li 1,
PMCID: PMC12977126  PMID: 21802640

Abstract

Human embryonic stem (hES)‐T3 (T3ES) cells were spontaneously differentiated into autogeneic fibroblast‐like T3DF cells, as feeder cells with the capacity to support the growth of undifferentiated hES cells. The proteomes of undifferentiated T3ES cells and their differentiated T3DF fibroblasts were quantitatively compared. Several heterogeneous nuclear ribonucleoproteins and glycolytic enzymes, including l‐lactate dehydrogenase A (M), were found to be abundantly and differentially expressed in T3ES cells and T3DF fibroblasts, respectively. Both miRNA and mRNA profiles from the undifferentiated T3ES cells and their differentiated T3DF fibroblasts had been previously determined. In this investigation, 206 genes were found to be targets of the four hES cell‐specific miRNAs of miR‐302d, miR‐372, miR‐200c, and/or miR‐367 by using two‐fold differential expression and inverse expression levels (highly negative correlations) of miRNAs to their target mRNAs. That YWHAZ (14‐3‐3 zeta) is a target of miR‐302d and miR‐372 was further confirmed by proteomic comparison between T3ES cells and their differentiated T3DF fibroblasts. According to GeneOntology analyses, almost 50% of these 206 target proteins are nuclear and are involved in gene transcription. Identifying the target mRNAs of hES cell‐specific miRNAs will provide a better understanding of the complex regulatory networks in hES cells. Furthermore, these miRNA‐targeted proteins play important roles in differentiation of hES cells and during embryo development.

Keywords: Fibroblasts, hESC, microRNAs, mRNAs, Proteomes

Introduction

Human embryonic stem (hES) cell lines have been derived from the inner cell mass of preimplantation embryos donated at in vitro fertilization clinics, and the undifferentiated growth of hES cells has been traditionally maintained on inactivated mouse embryonic fibroblasts (MEF) [[1], [2]]. These hES cell lines possess the remarkable abilities of both unlimited self‐renewal and pluripotency to generate any cell type differentiated from the three germ layers (the ectoderm, mesoderm, and endoderm) [3]. Thus, these hES cell lines have a great potential for use in cell therapy for regenerative medicine, as experimental models for drug discovery and toxicity testing, and for studying the basics of stem cell biology and molecular embryogenesis [4]. To reduce the risks of cross‐transfer of pathogens from xenogeneic feeders, an autogeneic feeder cell system, comprising fibroblast‐like cells differentiated from hES cells, was developed to grow undifferentiated and pluripotent hES cells for various medical applications [5].

The proteome of the hES autogeneic differentiated fibroblasts has not yet been investigated, although the proteome of undifferentiated hES cells has previously been reported [[6], [7]]. Proteomics has emerged as a robust method for performing large‐scale studies of proteins to complement high‐throughput gene expression analysis at the mRNA level. Two‐dimensional gel electrophoresis (2‐DE) is widely used in comparative studies of protein expression patterns between different cells to identify differentially expressed and/or modified proteins. The combination of 2‐DE and nanoflow liquid chromatography‐tandem mass spectrometry (LC‐MS/MS) is broadly applied to proteomic analyses of stem cells, including hES cells [[8], [9], [10]].

MicroRNAs (miRNAs) are noncoding RNAs of approximately 22 nucleotides in length that play important roles in mammalian embryo development and cell differentiation [[11], [12], [13], [14], [15]]. In humans and mice, several embryonic stem cell‐specific miRNAs have been reported [[16], [17], [18]]. These miRNAs were shown to be rapidly downregulated during differentiation, whereas miRNAs reported from other cell types were poorly expressed in embryonic stem cells. Identifying the target mRNAs of hES cell‐specific miRNAs is an important prerequisite for understanding the complex and interesting networks of regulation in hES cells.

Our laboratory had previously derived five hES cell lines [19], and autogeneic differentiated fibroblast‐like cells were established as feeders with the capacity to support the growth of undifferentiated hES cells [20]. In this investigation, the proteomes of undifferentiated hES‐T3 (T3ES) cells and their differentiated fibroblasts (T3DF) were quantitatively compared. Several heterogeneous nuclear ribonucleoproteins (hnRNPs) and glycolytic enzymes, including l‐lactate dehydrogenase A (M), were found to be abundantly and differentially expressed in the T3ES cells and their autogeneic T3DF fibroblasts. Additionally, 206 genes targeted by four hES cell‐specific miRNAs were identified, and YWHAZ (14‐3‐3 zeta) was confirmed to be a target of miR‐302d and miR‐372 by proteomic comparison between T3ES cells and their differentiated T3DF fibroblasts. About 50% of these 206 target proteins are nuclear and are involved in gene transcription.

Materials and methods

hES cell culture

The hES cell line hES‐T3, one of the five hES cell lines derived with institutional review board approval from preimplantation embryos donated at in vitro fertilization clinics in Taiwan, exhibits a normal female karyotype (46, XX). This cell line was continuously cultured on a mitotically inactivated MEF feeder layer in hES medium under 5% CO2 at 37°C and subjected to freezing/thawing processes as previously described [20]. The undifferentiated state of hES‐T3 cells (Passage 36) grown on MEF feeder layer was indicated by expression of OCT4 and NANOG, and these undifferentiated cells were designated as T3ES.

Establishment of autogeneic fibroblast‐like T3DF cells

Autogeneic feeder cells with the ability to support the growth of undifferentiated T3ES cells were established according to the previously published procedure [[5], [20]]. The hES‐T3 (Passage 19) cells were transferred into feeder‐free and noncoated plates (10 cm) in Dulbecco's Modified Eagle's Medium supplemented with 10% fetal bovine serum (GIBCO, Carlsbad, CA, USA) under 5% CO2 at 37°C. After 10 days, cells appeared as fibroblast‐like morphology, and these differentiated fibroblast‐like cells were designated as T3DF. These T3DF cells were passaged using trypsin (0.05%, GIBCO) every 4 days.

Two‐dimensional differential in‐gel electrophoresis of proteins

Protein samples from approximately 1 × 106 cells of T3ES and T3DF on each 10 cm plate were precipitated with 11% wt/vol trichloroacetic acid per 1 mL ice‐cold acetone at −20°C for 30 minutes. The pellets were washed twice with ice‐cold acetone and resuspended in a solubilizing buffer consisting of 7 M urea, 2 M thiourea, 4% CHAPS, and 30 mM Tris. Protein concentration was measured by the Bradford method. CyDye labeling was carried out according to the manufacturer's protocol (GE Healthcare, Little Chalfont, UK). In brief, 50 μg of proteins from T3ES and T3DF cells were labeled with Cy3 and Cy5 fluorescence dye, respectively, in the dark for 30 minutes. The sample labeling was stopped by the addition of 10 mM lysine for 10 minutes on ice in the dark. The two samples were then pooled and mixed with an equal volume of 2× sample buffer (7 M urea, 2 M thiourea, 2% wt/vol CHAPS, 1% immobilized pH gradient (IPG) buffer pH 3–10 nonlinear, 100 mM DeStreak reagent, and 0.002% bromophenol blue). Immobiline DryStrips (13 cm; pH 3–10 nonlinear; Amersham Biosciences, Uppsala, Sweden) were rehydrated for 10 hours in 250 μL rehydration solution [7 M urea, 2 M thiourea, 2% wt/vol CHAPS, 20 mM dithiothreitol (DTT), 0.5% IPG buffer, and 0.002% bromophenol blue]. Protein samples were loaded onto the strips using Ettan IPGphor cup‐loading (Amersham Biosciences) according to the manufacturer's protocol. Isoelectric focusing was carried out by an IPGphor apparatus (GE Healthcare) as follows: 350 V, step and hold, 3 hours; 650 V, gradient, 1 hour; 1,100 V, gradient, 1 hour; 8,000 V, gradient, 1.5 hour; and 8,000 V, step and hold, 3 hours, giving a total of 16,000 Vh. After focusing, the strips were equilibrated by shaking for 15 minutes in 5 mL equilibration buffer (50 mM Tris‐base, pH 8.8, 6 M urea, 30% vol/vol glycerol, 0.2% wt/vol sodium dodecyl sulfate, and 1% wt/vol DTT), followed by 5 mL of the same solution but with 2.5% wt/vol iodoacetamine instead of DTT for 15 minutes. Separation of the proteins in the second dimension was performed by sodium dodecyl sulfate‐polyacrylamide gel electrophoresis on a 12% wt/vol separation gel with a constant voltage of 65 V for 0.5 hours followed by 120 V for 14 hours. The separated gel was visualized with the Typhoon 9410 scanner (Amersham Biosciences, Uppsala, Sweden), and the images of the protein spots were quantified and numbered using the DeCyder Differential Analysis Software, Version 5.0 (Amersham Biosciences). The protein abundance of each spot was expressed as a percentage of total volume on the 2‐DE gel image. The proteins that were both abundantly (more than 0.1%) and differentially (more than three folds of changes) expressed were selected for LC‐MS/MS analysis.

LC‐MS/MS identification of proteins

The proteins of selected spots were digested in‐gel overnight at 37°C using sequencing grade trypsin (20 μL of 10 μg/mL in 25 mM ammonium bicarbonate, pH 8.5). The supernatant was used for analysis by nanoflow LC and Micromass quadrupole‐TOF (Micromass, Manchester, UK) Ultima Global mass spectrometer (Manchester, UK). Peptides were separated by a capillary LC system (Waters, Milford, CT), with a capillary analytical column (Symmetry C18, 75 μm ID, 100 mm; Waters), a desalting column (C18 PepMap, 300 μm ID, 5 mm; LC Packings, Sunnyvale, CA) and a switching valve. After on‐line desalting with 0.1% formic acid for 3 minutes, the switching valve was auto switched to an analytical position. The tryptic peptides were then separated over a reversed‐phased C18 column with a flow rate of 400 nL/min. Mobile phase A was 0.1% formic acid: acetonitrile = 95:5 (vol/vol) and mobile phase B was 0.1% formic acid: acetonitrile = 5:95(vol/vol). The LC gradient conditions were as follows: base on time (t) set at the mobile phase: t = 0–3 minutes, hold% B = 10; t = 3–45 minutes, %B from 10 to 75; and t = 45–60 minutes, %B from 75 to 100.

Peptides separated from the capillary column were directed to the nanospray source by a 20 μm i.d. and 90 μm o.d. fused‐silica capillary. A voltage of 3.2 kV was applied to the nanosource. The mass spectrometer was operated in positive ion mode with a cone voltage of 80 V and a source temperature of 80°C. The time‐of‐flight analyzer was set in the V‐mode. MS/MS spectra were acquired in a data‐dependent acquisition mode in which the two multiple‐charged (+2 and +3) peaks with the three most abundant ions were selected for collision‐induced dissociation. The parent ion was excluded if the same molecular weight ion was detected within 200 seconds. During the auto scans, collision energies were set at 10 V and 30 V, and argon was used as the collision gas. MS/MS spectra obtained for each of the parent ions were processed by MassLynx 4.0 software (Waters, Milford, MA) to get the corresponding peak lists. Proteins were identified by comparing experimental data with the NCBI nonredundant protein sequence database using the MASCOT search engine (http://www.matrixscience.com). The mascot score was −10 × log(P), where P is the probability that the observed match is a random event, with a cutoff p value of 0.05.

miRNA and mRNA analyses

Total RNA was extracted using TRIZOL reagent (Invitrogen, Carlsbad, CA), and the same total RNA from each sample was used for both miRNA quantification and mRNA microarray analysis [20]. The expression levels of 250 human miRNAs were determined using the TagMan MicroRNA Assays (Applied Biosystems, Foster City, CA) as described previously [[20], [21], [22]]. Purified mRNAs were analyzed using Affymetrix Human Genome U133 plus 2.0 GeneChip (Santa Clara, CA) according to the manufacturer's protocols. GeneChips from the hybridization experiments were read by the Affymetrix GeneChip scanner 3000, and raw data were processed using the GC‐RMA algorithm. The raw data were also analyzed by GeneSpring GX software version 7.3.1 (Silicon Genetics, Redwood City, CA).

Target prediction of miRNAs

The miRNAs negatively regulate posttranscriptional expression by translational repression and/or destabilization of protein‐coding mRNAs. Recent studies have revealed the impact that miRNAs can have on protein output. Although some targets were repressed without detectable changes in mRNA levels, those that were translationally repressed by more than a third additionally displayed detectable mRNA destabilization; and, for the more highly repressed targets, mRNA destabilization was usually the major component of repression [[23], [24]]. The potential target genes of hES cell‐specific miRNAs were predicted using the PicTar (four‐way, http://pictar.bio.nyu.edu/) and TargetScanS (http://www.targetscan.org/) with a cutoff p value less than 0.05 [25]. The expression levels of the predicted target mRNAs were first analyzed by the Volcano plot using the parametric test and Benjamini‐Hochberg false discovery rate for multiple testing correction. The abundantly and differentially expressed mRNAs were selected by more than a three‐fold overall mean in T3DF cells and changes of more than two‐fold (rather than three‐fold) between T3DF and T3ES cells with a p value cutoff of 0.05. The negative correlation coefficients between miRNAs and their target mRNAs were calculated to demonstrate their inverse expression levels [20].

GeneOntology of hES cell‐specific miRNA targets

The GeneOntology, including molecular functions and cellular localization, of differentially expressed, abundant targets of hES cell‐specific miRNAs were analyzed using GeneSpring GX software version 7.3.1 GeneOntology Browser and MetaCore Analytical Suite (GeneGo Inc., St Joseph, MI). The current NetAffx annotation of transcript 26, dated July 8, 2008 was used for analyzing molecular functions of miRNA targets [20].

Results

Two‐dimensional differential in‐gel electrophoresis analysis and protein identification

Soluble proteins from T3ES and T3DF cells were separately labeled with Cy3 and Cy5, respectively, and then pooled together for comparison on a single two‐dimensional differential in‐gel electrophoresis (2D‐DIGE). The fluorescently labeled proteins on 2D‐DIGE were imaged using a Typhoon 9410 Variable Mode Imager (Fig. 1). The abundance of 884 protein spots was quantitated using DeCyder differential in‐gel analysis software, and expressed as a percentage of total volume. The relative fold changes in protein expression levels were estimated by the fluorescent ratios of either Cy3%/Cy5% (T3ES/T3DF) or Cy5%/Cy3% (T3DF/T3ES). A total of 115 protein spots were selected for LC‐MS/MS analyses, including 46 (green) and 66 (red) abundant (more than 0.1%) protein spots with more than three‐fold changes, as well as three (yellow) protein spots of similarly abundant expression levels, from T3ES and T3DF cells. A sum of 64 protein spots, including 17 green, 44 red, and 3 yellow, were identified (Fig. 2, Supplementary Table S1). Interestingly, 13 of 17 differentially expressed abundant protein spots (green) in T3ES cells were found to be hnRNPs, and each of the 3 hnRNP proteins (A1, H1, and L) appeared to have two spots of different charges. Among the 44 differentially expressed abundant protein spots (red) identified in T3DF cells, cellular retinoic acid binding protein 1 (CRABP 1) and heat shock protein 90 (Hsp90) were the two most abundantly expressed proteins (1.84% and 1.53%, respectively), and several glycolytic enzymes, including aldolase, triosephosphate isomerase, glyceraldehyde 3‐phosphate dehydrogenase, enolase, pyruvate kinase, and l‐lactate dehydrogenase A (M), were also found to be abundantly and differentially expressed. Actins and translation elongation factor 1 were abundantly expressed at similar levels between the T3ES and T3DF cells.

Figure 1.

Figure 1

Cy3 (green), Cy5 (red), and merged images. The proteins from human embryonic stem (hES)‐T3 (T3ES) and T3 differentiated fibroblasts (T3DF) cells were labeled with (A) Cy3 (green) or (B) Cy5 (red), and the fluorescent images were obtained using a Typhoon 9410 Imager. (C) Cy3 and Cy5 images were merged, and yellow spots indicate the proteins with similar abundant expression levels in T3ES and T3DF cells.

Figure 2.

Figure 2

Identification of abundant protein spots with higher than three‐fold changes. (A) Seventeen Cy3 (green) spots in which the proteins were predominantly from human embryonic stem (hES)‐T3 cells; (B) Forty‐four Cy5 (red) spots in which the proteins were predominantly from T3 differentiated fibroblasts cells. Three yellow spots (427, 515, and 527) consisting similar abundant expression levels on Cy3 and Cy5 appeared of both A and B.

Target identification of miRNAs expressed highly in hES cells

The genome‐wide mRNA expression in both undifferentiated hES cells hES‐T3 (T3ES) and hES‐T3 differentiated fibroblast‐like cells (T3DF) was determined using the Affymetrix human genome U133 plus 2.0 GeneChip. The original data had been deposited in the NCBI database (GSE9440), and the results were described previously [20]. The expression levels of 250 human miRNAs in T3ES and T3DF cells were quantitated using TagMan MicroRNA Assays as described previously [[21], [22]]. The four hES cell‐specific miRNAs (miR‐302d, miR‐367, miR‐372, and miR‐200c) were found to be expressed abundantly (at levels higher than 20‐fold that of U6 snRNA) in T3ES cells, but at low levels (0.03‐fold of U6 snRNA) in T3DF cells [20]. The potential targets of these four hES cell‐specific miRNAs were predicted using both the PicTar and the TargetScanS methods. The expression levels of their target mRNAs in T3ES and T3DF cells were analyzed by the Volcano plot, and 206 genes targeted by these four miRNAs were identified using two‐fold differential expression and inverse expression levels (negative correlations) between miRNAs and their target mRNAs (Supplementary Table S2).

Proteomic confirmation of the miRNA target YWHAZ

The YWHAZ (14‐3‐3 zeta) protein targeted by miR‐302d and miR‐372 was found to be in common between the 44 abundantly and differentially expressed proteins in T3DF cells (Supplementary Table S1B) and the 206 targets of the 4 hES cell‐specific miRNAs miR‐302d, miR‐372, miR200c, and/or miR‐367 (Supplementary Table S2). The positions and abundance (measured as the volume) of this YWHAZ protein spot (756) on Cy3 and Cy5 images are indicated in Fig. 3. The results of LC‐MS/MS identification and expression ratio of YWHAZ proteins, as well as its mRNAs, between T3DF and T3ES cells are given in Table 1. The expression ratio (T3DF/T3ES = 3.35) of YWHAZ protein was consistent with that (T3DF/T3ES = 2.49/1.06 = 2.35) of its mRNAs [20].

Figure 3.

Figure 3

The positions and abundance (in volume) of the YWHAZ protein on Cy3 and Cy5 images. (A) Spot 756 on Cy3; (B) Spot 756 on Cy5; (C) Volume of spot 756 on Cy3; (D) Volume of spot 756 on Cy5.

Table 1.

Proteomic identification of miRNA target YWHAZ

LC‐MS/MS identification Score, 195 5 Peptides matched
aa 42–49 NLLSVAYK
aa 84–91 EKIETEIR
aa 104–115 FLIPNASQAESK
aa 128–139 YLAEVAAGDDKK
aa 213–222 DSTLIMOLLR

Unigene: Hs.693311; Ratio of mRNAs (data from Li et al. [20].): T3DF/T3ES  =  2.49/1.06  =  2.35.

Protein spot 756: fold changes of Cy5%/Cy3% on 2D‐DIGE  =  3.35.

LC‐MS/MS  =  liquid chromatography‐tandem mass spectrometry; T3DF  =  T3 differentiated fibroblasts; T3ES  =  human embryonic stem (hES)‐T3; YWHAZ  =  14‐3‐3 protein zeta  =  tyrosine 3/tryptophan 5‐monooxygenase activation protein, zeta isoform.

Molecular functions of hES cell‐specific miRNA targets

The molecular functions of the 206 genes targeted by the four hES cell‐specific miRNAs miR‐302d, miR‐372, miR‐200c, and/or miR‐367 were analyzed using the GeneSpring GeneOntology Browser and MetaCore Analytical Suite (Table 2). The top four molecular functions of the eight categories obtained by GeneSpring were the same as those obtained by MetaCore. All of the top four molecular functions are involved in gene transcription. As to their cellular locations, 102 targets (p value of 2.2E‐07) of these 206 genes were localized in nucleus.

Table 2.

Molecular functions of 206 abundantly and differentially expressed targets

Molecular functions GeneSpring MetaCore
Probes a p Genes p
Nucleic acid binding 203 4.11 × 10−26 95 2.93 × 10−9
Transcription regulator activity 133 1.21 × 10−20 69 4.14 × 10−16
DNA binding 123 3.86 × 10−17 84 6.46 × 10−13
Transcription factor activity 116 1.05 × 10−14 58 3.46 × 10−17
Receptor binding 50 1.35 × 10−5
Nuclease activity 28 1.46 × 10−5
Protein kinase activity 38 3.21 × 10−5
Nucleotide binding 53 1.18 × 10−4
Sequence‐specific DNA binding 39 2.84 × 10−14
Transcription activator activity 25 5.03 × 10−9
Chromatin DNA binding 6 7.65 × 10−9
Transcription factor binding 22 1.91 × 10−5
a

A total of 759 probes for 206 genes.

Discussion

Proteomics can provide a powerful approach for comparing the characteristics of hES cells with their autogeneic differentiated fibroblasts. Thus, the proteomes of undifferentiated T3ES cells and their fully differentiated T3DF fibroblasts were quantitatively compared in this investigation. In the proteome of T3ES cells, hES cell‐specific markers, such as OCT4, NANOG, and SOX2, were not detected among abundantly and differentially expressed proteins, whereas 13 of 17 abundantly and differentially expressed protein spots were found to be hnRNP proteins. The hnRNP proteins C and L were also reported to be enriched in undifferentiated hES cells but downregulated in differentiated embryoid bodies [26]. Our finding of abundant hnRNP proteins in undifferentiated hES cells is consistent with the high ratio of nucleus to cytoplasm in hES cells [1] because hnRNP proteins are among the most abundant proteins in the nucleus [27].

In humans, hnRNP proteins consist of a large group (more than 20) of nuclear RNA binding proteins, and they are given alphabetical names based on size from hnRNP A1 to hnRNP U. The hnRNP proteins A1 and M were found to be the two most abundantly expressed proteins (2.15% and 1.42%, respectively) in this investigation. The hnRNP proteins play important roles in alternative mRNA splicing and mRNA localization. Alternative mRNA splicing is a critical process that ensures the production of numerous proteins from a limited set of human genes [28]. Alternative splicing can also remove binding sites for posttranscriptional repression by miRNAs [29], and alternative splicing has recently been shown to regulate mouse embryonic stem cell pluripotency and differentiation [30]. It should further be noted that each of the three hnRNP proteins (A1, H1, and L) appeared to have two spots of different charges. The extremely abundant expression and multiple spots of hnRNP proteins indicate a very active pre‐mRNA processing (i.e. alternative mRNA splicing) and the important role of posttranslational modifications on hnRNP protein functions in hES cells. The exact nature of posttranslational modifications (phosphorylation of Ser/Thr and/or methylation of Arg) and how these posttranslational modifications affect the functions of hnRNP proteins in hES cells remain to be investigated.

Regarding the proteome of autogeneic fibroblast‐like T3DF cells, the abundant expression of several glycolytic enzymes, including l‐lactate dehydrogenase A (M), is consistent with the more anaerobic metabolism of fibroblasts. The multiple spots observed for annexin A2, enolase 1, galectin1, lamin A/C, and the eukaryotic translation elongation factor 2 may be because of different splicing isoforms and/or posttranslational modifications. Among the 44 abundantly and differentially expressed protein spots identified, CRABP 1, and Hsp90 were the two most abundantly expressed proteins. The CRABP 1 plays an important role in retinoic acid‐mediated differentiation and proliferation processes. It is structurally similar to the cellular retinol‐binding proteins but binds only retinoic acid at specific sites within the nucleus; this may contribute to vitamin A‐directed differentiation in epithelial tissue. Hsp90 plays a well‐known role of cytoplasmic‐nuclear transport of steroid receptors as a molecular chaperone. Furthermore, incorporation of the Argonaute RNA‐binding proteins into cytoplasmic P‐bodies is mediated by Hsp90, and inhibition of Hsp90 interferes with posttranscriptional gene silencing by miRNAs [31].

The miRNA lin4 was first discovered to be essential for the normal temporal control of diverse postembryonic developmental events in nematodes by regulating lin14 mRNA translation via an antisense RNA‐RNA interaction [32]. Thus, miRNAs may play important roles in the unlimited self‐renewal and pluripotency of hES cells. In our previous report [20], profiles of both miRNAs and mRNAs from the undifferentiated T3ES cells and their differentiated fibroblast‐like T3DF cells were determined, and 58 genes were found to be targets of the four hES cell‐specific miRNAs of miR‐302d, miR‐372, miR‐200c, and/or miR‐367 when a three‐fold differential expression and inverse expression levels (highly negative correlation) of miRNAs to their target mRNAs was used. In this investigation, 206 genes were found to be targeted by these four hES cell‐specific miRNAs when a two‐fold, instead of three‐fold, differential expression was used.

As noted previously [20], the genes/proteins targeted by hES‐specific miRNAs play important roles in hES cell differentiation and embryo development. For example, the tricho‐rhino‐phalangeal syndrome type 1 (TRPS1) zinc finger transcription factor regulates bone development, and the TRPS1 malformation syndrome is characterized by distinctive craniofacial and skeletal abnormalities. The Kruppel‐like factor 13 gene encodes another zinc finger transcription factor, and Kruppel‐like factor 13 protein is the dominant transactivator of the RANTES gene induced at T‐cell differentiation stage. The human MBNL2 gene encodes a protein related to the Drosophila muscle blind protein 2, and this protein may play a role in the expansion of short nucleotide repeats resulting in myotonic dystrophy. That YWHAZ (14‐3‐3 zeta) is a target of miR‐302d and miR‐372 was further confirmed by the proteomic comparison between T3ES and T3DF cells in this investigation. The YWHAZ protein belongs to the 14‐3‐3 family of conserved regulatory molecules expressed in all eukaryotic cells. The 14‐3‐3 proteins have the ability to bind numerous functionally diverse signaling proteins, including kinases, phosphatases, and transmembrane receptors. The 14‐3‐3 zeta was found to be overexpressed in early breast cancers and to downregulate the expression of p53 [33]. Recently, 253 target mRNAs of the mouse miR‐290 cluster (corresponding to the human miR‐302 cluster) were found by transcriptome analysis of embryonic stem cells lacking Dicer of the miRNA processing enzyme [34]. A comparison of the 206 human targets with the 253 mouse targets revealed 14 common targets, namely, MTUS1, NF1B, DAZAP2, MBNL2, PLEKHA3, TRPS1, ZBTB7A, ZMYND11, DIP2A, FURIN, RHOV, STK38, SYNJ1, and SRPK2. Regarding the molecular functions of 206 human targets, four of top eight categories were involved in gene transcription; except for their order, these top four categories were the same as those identified for 58 targets reported previously [20]. In other words, almost 50% of these 206 target proteins were located in the nucleus and were involved in gene transcription.

In summary, 206 genes targeted by four hES‐specific miRNAs were identified, the proteins of which play important roles in hES cell differentiation and embryo development. YWHAZ, which belongs to the 14‐3‐3 family of conserved regulatory molecules expressed in all eukaryotic cells, is a target of miR‐302d and miR‐372, as confirmed by the proteomic analysis in this investigation. These results will provide a better understanding of the complex regulatory networks involved in hES cell differentiation.

Acknowledgments

The authors thank the research assistants at the Microarray Core Facility of National Research Program for Genomic Medicine of National Science Council in Taiwan at National Taiwan University college of Medicine for their technical assistance. This research was supported in part by a grant (NSC‐98‐2314‐B‐037‐024‐MY3) from the National Science Council of Taiwan.

Supporting information

Supplementary data

KJM2-27-299-s001.doc (156KB, doc)

Supplementary material

Supplementary material can be found, in the online version, at doi:10.1016/j.kjms.2011.03.010.

References

  • [1]. Thomson J.A., Itskovitz‐Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998; 282: 1145–1147. [DOI] [PubMed] [Google Scholar]
  • [2]. Guhr A., Kurtz A., Friedgen K., Loser P.. Current state of human embryonic stem cell research: an overview of cell lines and their use in experimental work. Stem Cells. 2006; 24: 2187–2191. [DOI] [PubMed] [Google Scholar]
  • [3]. Reubinoff B.E., Pera M.F., Fong C.Y., Trounson A., Bongso A.. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol. 2000; 18: 399–404. [DOI] [PubMed] [Google Scholar]
  • [4]. Wobus A.M., Boheler K.R.. Embryonic stem cells: prospects for developmental biology and cell therapy. Physiol Rev. 2005; 85: 635–678. [DOI] [PubMed] [Google Scholar]
  • [5]. Stojkovic P., Lako M., Stewart R., Przyborski S., Armstrong L., Evans J., et al. An autogeneic feeder cell system that efficiently supports growth of undifferentiated human embryonic stem cells. Stem Cells. 2005; 23: 306–314. [DOI] [PubMed] [Google Scholar]
  • [6]. Baharvand H., Hajheidari M., Ashtiani S.K., Salekdeh G.H.. Proteomic signature of human embryonic stem cells. Proteomics. 2006; 6: 3544–3549. [DOI] [PubMed] [Google Scholar]
  • [7]. Van Hoof D., Passier R., Ward‐Van Oostwaard D., Pinkse M.W., Heck A.J., Mummery C.L., et al. A quest for human and mouse embryonic stem cell‐specific proteins. Mol Cell Proteomics. 2006; 5: 1261–1273. [DOI] [PubMed] [Google Scholar]
  • [8]. Baharvand H., Fathi A., van Hoof D., Salekdeh G.H.. Concise review: trends in stem cell proteomics. Stem Cells. 2007; 25: 1888–1903. [DOI] [PubMed] [Google Scholar]
  • [9]. Van Hoof D., Heck A.J., Krijgsveld J., Mummery C.L.. Proteomics and human embryonic stem cells. Stem Cell Res. 2008; 1: 169–182. [DOI] [PubMed] [Google Scholar]
  • [10]. Roche S., Delorme B., Oostendorp R.A., Barbet R., Caton D., Noel D., et al. Comparative proteomic analysis of human mesenchymal and embryonic stem cells: towards the definition of a mesenchymal stem cell proteomic signature. Proteomics. 2009; 9: 223–232. [DOI] [PubMed] [Google Scholar]
  • [11]. Bartel D.P.. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116: 281–297. [DOI] [PubMed] [Google Scholar]
  • [12]. John B., Enright A.J., Aravin A., Tuschl T., Sander C., Marks D.S.. Human MicroRNA targets. PLoS Biol. 2004; 2: e363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [13]. Alvarez‐Garcia I., Miska E.A.. MicroRNA functions in animal development and human disease. Development. 2005; 132: 4653–4662. [DOI] [PubMed] [Google Scholar]
  • [14]. Kloosterman W.P., Plasterk R.H.. The diverse functions of microRNAs in animal development and disease. Dev Cell. 2006; 11: 441–450. [DOI] [PubMed] [Google Scholar]
  • [15]. Landgraf P., Rusu M., Sheridan R., Sewer A., Iovino N., Aravin A., et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. 2007; 129: 1401–1414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [16]. Houbaviy H.B., Murray M.F., Sharp P.A.. Embryonic stem cell‐specific MicroRNAs. Dev Cell. 2003; 5: 351–358. [DOI] [PubMed] [Google Scholar]
  • [17]. Suh M.R., Lee Y., Kim J.Y., Kim S.K., Moon S.H., Lee J.Y., et al. Human embryonic stem cells express a unique set of microRNAs. Dev Biol. 2004; 270: 488–498. [DOI] [PubMed] [Google Scholar]
  • [18]. Laurent L.C., Chen J., Ulitsky I., Mueller F.J., Lu C., Shamir R., et al. Comprehensive microRNA profiling reveals a unique human embryonic stem cell signature dominated by a single seed sequence. Stem Cells. 2008; 26: 1506–1516. [DOI] [PubMed] [Google Scholar]
  • [19]. Li S.S., Liu Y.H., Tseng C.N., Chung T.L., Lee T.Y., Singh S.. Characterization and gene expression profiling of five new human embryonic stem cell lines derived in Taiwan. Stem Cells Dev. 2006; 15: 532–555. [DOI] [PubMed] [Google Scholar]
  • [20]. Li S.S., Yu S.L., Kao L.P., Tsai Z.Y., Singh S., Chen B.Z., et al. Target identification of microRNAs expressed highly in human embryonic stem cells. J Cell Biochem. 2009; 106: 1020–1030. [DOI] [PubMed] [Google Scholar]
  • [21]. Chen C., Ridzon D.A., Broomer A.J., Zhou Z., Lee D.H., Nguyen J.T., et al. Real‐time quantification of microRNAs by stem‐loop RT‐PCR. Nucleic Acids Res. 2005; 33: e179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [22]. Chen C., Ridzon D., Lee C.T., Blake J., Sun Y., Strauss W.M.. Defining embryonic stem cell identity using differentiation‐related microRNAs and their potential targets. Mamm Genome. 2007; 18: 316–327. [DOI] [PubMed] [Google Scholar]
  • [23]. Baek D., Villen J., Shin C., Camargo F.D., Gygi S.P., Bartel D.P.. The impact of microRNAs on protein output. Nature. 2008; 455: 64–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [24]. Guo H., Igolia N.T., Weissman J.S., Bartel D.P.. Mammalian microRNAs predominantly act to decrease target mRNA lelvels. Nature. 2010; 466: 835–840. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [25]. Sethupathy P., Megraw M., Hatzigeorgiou A.G.. A guide through present computational approaches for the identification of mammalian microRNA targets. Nat Methods. 2006; 3: 881–886. [DOI] [PubMed] [Google Scholar]
  • [26]. Fathi A., Pakzad M., Taei A., Brink T.C., Pirhaji L., Ruiz G., et al. Comparative proteome and transcriptome analyses of embryonic stem cells during embryoid body‐based differentiation. Proteomics. 2009; 9: 4859–4870. [DOI] [PubMed] [Google Scholar]
  • [27]. Dreyfuss G., Matunis M.J., Pinol‐Roma S., Burd C.G.. hnRNP proteins and the biogenesis of mRNA. Annu Rev Biochem. 1993; 62: 289–321. [DOI] [PubMed] [Google Scholar]
  • [28]. Venables J.P., Koh C.S., Froehlich U., Lapointe E., Couture S., Inkel L., et al. Multiple and specific mRNA processing targets for the major human hnRNP proteins. Mol Cell Biol. 2008; 28: 6033–6043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [29]. Duursma A.M., Kedde M., Schrier M., le Sage C., Agami R.. miR‐148 targets human DNMT3b protein coding region. RNA. 2008; 14: 872–877. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [30]. Salomonis N., Schlieve C.R., Pereira L., Wahlquist C., Colas A., Zambon, et al. Alternative splicing regulates mouse embryonic stem cell pluripotency and differentiation. Proc Natl Acad Sci USA. 2010; 107: 10514–10519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [31]. Pare J.M., Tahbaz N., Lopez‐Orozco J., LaPointe P., Lasko P., Hobman T.C.. Hsp90 regulates the function of argonaute 2 and its recruitment to stress granules and P‐bodies. Mol Biol Cell. 2009; 20: 3273–3284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [32]. Lee R.C., Feinbaum R.L., Ambros V.. The C. elegans heterochronic gene lin‐4 encodes small RNAs with antisense complementarity to lin‐14. Cell. 1993; 75: 843–854. [DOI] [PubMed] [Google Scholar]
  • [33]. Danes C.G., Wyszomierski S.L., Lu J., Neal C.L., Yang W., Yu D., et al. 14‐3‐3 zeta down‐regulates p53 in mammary epithelial cells and confers luminal filling. Cancer Res. 2008; 68: 1760–1767. [DOI] [PubMed] [Google Scholar]
  • [34]. Sinkkonen L., Hugenschmidt T., Berninger P., Gaidatzis D., Mohn F., Artus‐Revel C.G., et al. MicroRNAs control de novo DNA methylation through regulation of transcriptional repressors in mouse embryonic stem cells. Nat Struct Mol Biol. 2008; 15: 259–267. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary data

KJM2-27-299-s001.doc (156KB, doc)

Articles from The Kaohsiung Journal of Medical Sciences are provided here courtesy of Kaohsiung Medical University and John Wiley & Sons Australia, Ltd

RESOURCES